The team included researchers from the UK’s University of Leicester, the University of Cambridge and Australia’s Baker Heart and Diabetes Institute.
UK Biobank genomic data from 500,000 people, including more than 22,000 coronary heart disease patients, aged between 40-69 years was used to create and test the GRS.
The scoring system can analyse 1.7 million genetic variants in a person’s DNA and calculate their risk of developing coronary heart disease prematurely.
